You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MIF (MIF) Antibodies

Full name:
anti-Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) Antibodies (MIF)
On www.antibodies-online.com are 202 Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) Antibodies from 33 different suppliers available. Additionally we are shipping MIF Kits (86) and MIF Proteins (75) and many more products for this protein. A total of 373 MIF products are currently listed.
Synonyms:
GIF, GLIF, LOC100136498, LOC100284350, LOC100284546, Mif, MMIF

Most Popular Reactivities for anti-MIF (MIF) Antibodies

Select your species and application

anti-Mouse (Murine) MIF Antibodies:

anti-Human MIF Antibodies:

anti-Rat (Rattus) MIF Antibodies:

All available anti-MIF Antibodies

Go to our pre-filtered search.

Top referenced anti-MIF Antibodies

  1. Human Polyclonal MIF Primary Antibody for EIA, WB - ABIN118028 : Bernhagen, Calandra, Mitchell, Martin, Tracey, Voelter, Manogue, Cerami, Bucala: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. in Nature 1993 (PubMed)
    Show all 11 references for ABIN118028

  2. Human Polyclonal MIF Primary Antibody for FACS, WB - ABIN4899419 : Chuang, Hung, Tsai, Yeh, Chuang et al.: High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic ... in Critical care medicine 2004 (PubMed)
    Show all 9 references for ABIN4899419

  3. Human Polyclonal MIF Primary Antibody for EIA, ELISA - ABIN250498 : Hsieh, Su, Wang, Tsai, Huang, Chang, Lai, Lei, Huang: Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. in Molecular cancer research : MCR 2007 (PubMed)
    Show all 3 references for ABIN250498

  4. Human Monoclonal MIF Primary Antibody for EIA, IHC (p) - ABIN121160 : Weiser, Temple, Witek-Giannotti, Remold, Clark, David: Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. in Proceedings of the National Academy of Sciences of the United States of America 1989 (PubMed)
    Show all 3 references for ABIN121160

  5. Human Polyclonal MIF Primary Antibody for EIA, WB - ABIN374566 : Church, Willis, Priest, Lamonte, Earnest, Wilkinson, Wilson, Giroir: Obesity, macrophage migration inhibitory factor, and weight loss. in International journal of obesity (2005) 2005 (PubMed)

More Antibodies against MIF Interaction Partners

Xenopus laevis Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. MIF was found to be essential for axis formation and neural development of Xenopus embryos.

Zebrafish Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. Data show that the mif pathway is required for both sensory hair cell (HC) and sensory neuronal cell survival in the ear, for HC differentiation, semicircular canal formation, statoacoustic ganglion (SAG (show SAG Antibodies)) development, and lateral line HC differentiation.

Mouse (Murine) Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. findings suggest that macrophage migration inhibitory factor regulates extramedullary erythropoiesis by inhibiting an overexpansion of splenic immature erythroid cells during chronic stress and indicate a novel role for this cytokine under chronic stress conditions

  2. Findings suggest that Mif plays a role in the molecular mechanisms of macrophage and dendritic cell activation and drives T cell responses involved in the pathology of type 1 diabetes mellitus.

  3. MIF has a potential role in pathological angiogenesis of proliferative retinopathy.

  4. genetic Mif deletion reduces the incidence and severity of oral carcinogenesis, by inhibiting the expression of chronic pro-inflammatory immune mediators. Thus, targeting MIF is a promising strategy for the prevention or therapy of oral cancer.

  5. MIF inhibits the myoblast differentiation by affecting the cell cycle progression, but does not affect proliferation.

  6. this paper shows that the detrimental effect of MIF knockout was associated with accentuated loss in cardiac autophagy with aging

  7. our results suggest that MIF promotes mCSC (show SLC25A25 Antibodies) survival, proliferation and endothelial differentiation through the activation of the PI3K/Akt (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) and AMPK (show PRKAA1 Antibodies) signaling pathways.

  8. Posttranslational modification of MIF by S-nitrosation results in intracellular accumulation and protection from myocardial ischemia reperfusion injury.

  9. Data show that the siRNA-induced macrophage migration inhibitory factor (MIF) reduction in murine mammary cancer line 4T1 and human breast cancer line MDA-MB-231 resulted in significant reduction of cell proliferation and increase of apoptosis.

  10. High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Human Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. MDA, MIF (show AMH Antibodies), and LDL-C/HDL (show HSD11B1 Antibodies)-C could be new predictors of metabolic disturbance which promote vascular complications in T2DM.

  2. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.(

  3. Serum levels of MIF (show AMH Antibodies) are significantly higher in patients with chronic obstructive pulmonary disease compared with controls.

  4. Macrophage Migration Inhibitory Factor-CXCR4 (show CXCR4 Antibodies) Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE (show CXCL12 Antibodies).

  5. Study demonstrated that DDT (show DDT Antibodies) was over- expressed in pancreatic ductal adenocarcinoma (PDAC) tissues and cell lines in a pattern correlated with MIF (show AMH Antibodies), and knockdown of DDT (show DDT Antibodies) and MIF (show AMH Antibodies) in PANC- 1 cells cooperatively inhibited cell proliferation, invasion and tumor formation. The tautomerase activities of both MIF (show AMH Antibodies) and DDT (show DDT Antibodies) are required for their negative regulatory role in p53 (show TP53 Antibodies) and their tumor-promoting functions.

  6. Results suggest that MIF (show AMH Antibodies) -173 G/C variant increases the risk of HBV in Iranian subjects.

  7. Results identify the CXCL2 (show CXCL2 Antibodies)/MIF (show AMH Antibodies)-CXCR2 (show CXCR2 Antibodies) axis as an important mediator in MDSC recruitment and as predictors in bladder cancer.

  8. Chronic-stage serum MIF (show AMH Antibodies) levels were significantly lower than acute-stage serum MIF (show AMH Antibodies) levels (p < 0.001) in patients with acute ischemic stroke and were similar to serum MIF (show AMH Antibodies) levels in the controls (p = 0.392).

  9. this study identifed macrophage migration inhibitory factor (MIF) as a PARP-1 (show PARP1 Antibodies)-dependent AIF (show AIFM1 Antibodies)-associated nuclease (show DCLRE1C Antibodies) (PAAN).

  10. The results showed that miR (show MLXIP Antibodies)-451 could play a role in development and progression of colorectal cancer and likely by targeting MIF (show AMH Antibodies)

Cow (Bovine) Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. Data suggest that, in obese cows, expression of MIF is suppressed in the ampulla and isthmus of Fallopian tubes as compared to normal-weight cows; however, MIF expression is also lower in Fallopian tubes of lean cows. The primary site of MIF expression in Fallopian tube ampulla/isthmus is the tunica mucosa. These studies were conducted in Japanese Black calves.

  2. The objective of the present study was to determine if SNPs in 5' region of bovine MIF affects its promoter activity.

  3. MIF plays a role in early embryo development, and further characterization of MIF expression and its regulation in the endometrium will add significantly to our understanding of early embryo-uterine interactions

  4. The diverse actions of MIF within the immuno-neuroendocrine system may be a result of its occurrence in different isoforms and oligomerization states.

  5. The purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol and its partial characterization are reported.

Pig (Porcine) Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor) (MIF) interaction partners

  1. Transcription of MIF is induced by activation of PPARgamma2 (show PPARG Antibodies) and inhibited by excessive resistin (show RETN Antibodies).

  2. The high activity of MIF in the maternal and fetal tissues throughout placentation and its expression in the nonpregnant uterus indicate a regulatory role for MIF during embryo receptivity and epitheliochorial placentation

MIF Antigen Profile

Antigen Summary

This gene encodes a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation. It plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways.

Alternative names and synonyms associated with MIF

  • macrophage migration inhibitory factor (glycosylation-inhibiting factor) (mif) antibody
  • macrophage migration inhibitory factor (mif) antibody
  • macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF) antibody
  • macrophage migration inhibitory factor (Mif) antibody
  • macrophage migration inhibitory factor (PHATRDRAFT_49660) antibody
  • macrophage migration inhibitory factor (LOC100136498) antibody
  • Macrophage migration inhibitory factor (mif) antibody
  • macrophage migration inhibitory factor (LOC100284350) antibody
  • macrophage migration inhibitory factor (LOC100284546) antibody
  • macrophage migration inhibitory factor (LOC100338701) antibody
  • macrophage migration inhibitory factor (MIF) antibody
  • macrophage migration inhibitory factor (glycosylation-inhibiting factor) (Mif) antibody
  • GIF antibody
  • GLIF antibody
  • LOC100136498 antibody
  • LOC100284350 antibody
  • LOC100284546 antibody
  • Mif antibody
  • MMIF antibody

Protein level used designations for MIF

L-dopachrome isomerase , L-dopachrome tautomerase , Phenylpyruvate tautomerase , macrophage migration inhibitory factor , phenylpyruvate tautomerase , Macrophage migration inhibitory factor , DER6 , delayed early response protein 6 , glycosylation-inhibiting factor , glutathione-binding 13 kDa protein , p12A , GIF

GENE ID SPECIES
399041 Xenopus laevis
503499 Takifugu rubripes
574298 Macaca mulatta
692890 Bombyx mori
751093 Danio rerio
7198303 Phaeodactylum tricornutum CCAP 1055/1
100134996 Xenopus (Silurana) tropicalis
100136346 Oncorhynchus mykiss
100136498 Salmo salar
100196518 Salmo salar
100284350 Zea mays
100284546 Zea mays
17319 Mus musculus
100338701 Oryctolagus cuniculus
595146 Canis lupus familiaris
4282 Homo sapiens
81683 Rattus norvegicus
280858 Bos taurus
100719548 Cavia porcellus
397412 Sus scrofa
100857237 Gallus gallus
780466 Ovis aries
Selected quality suppliers for anti-MIF (MIF) Antibodies
Did you look for something else?